Who
Peter J. Wilkinson
SVP, Chief Accounting Officer
Company insider
Files Form 4 as: SVP, Chief Accounting Officer, Labcorp Holdings; VP of Fin./Chief Acctg. Off., Pharmaceutical Product Development.
In numbers
- Trades disclosed
- 171
- Buys
- 0
- Sells
- 13
- Bought
- $0
- Sold
- $5.1M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 16 May 2007
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $25K82 at $309.22 | filing |
| 3 Aug 2026filed 5 Aug 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | $280K1,338 at $209.25 | filing |
| 3 Aug 2026filed 5 Aug 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $414K1,338 at $309.23 | filing |
| 3 Aug 2026filed 5 Aug 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,338 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,338 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $25K82 at $309.22 | filing |
| 3 Aug 2026filed 5 Aug 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | $280K1,338 at $209.25 | filing |
| 3 Aug 2026filed 5 Aug 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $414K1,338 at $309.23 | filing |
| 27 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $436K1,633 at $267.05 | filing |
| 27 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $436K1,633 at $267.05 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,388 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $203K755 at $268.38 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,388 at $0.00 | filing |
| 26 Mar 2026filed 30 Mar 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $203K755 at $268.38 | filing |
| 19 Feb 2026filed 23 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $185K666 at $277.94 | filing |
| 19 Feb 2026filed 23 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $185K666 at $277.94 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —536 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $46K160 at $289.89 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —160 | filing |
| 11 Feb 2026filed 13 Feb 2026 | LH Labcorp Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —536 at $0.00 | filing |
News
Labcorp To Acquire BioReference Health Assets; OPKO Shares Rise 7.35%LH · rttnews.com · 15 Oct 2026Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference HealthLH · prnewswire.com · 15 Oct 2026Labcorp (LH): Is Its Earnings Discount Worth the Growing Investment Bill?LH · insidermonkey.com · 12 Oct 2026
0 headlines in the last 90 days name Peter J. Wilkinson; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.